Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2025-12-25 @ 8:10 PM
NCT ID:
NCT05082935
Group ID:
EG001
Title:
Active Comparator, Residential Density-located Venue Placement Strategy
Description:
This is the Phase I study (Clinical Trial ID: NCT04793464) and is comprised of the "Promotores", "Control", and "Unknown Treatment Status" Arms/Groups from the Phase I study. For all Phase I study activities, testing events re-occurred every two weeks at the same location and time, based on census density on Latinx individuals for site selection.
Promotores de Salud intervention arm consists of outreach to promote testing and vaccination at re-occurring testing events that have been selected for sites that have a high residential density of Latinx persons. At the testing events, it includes the on-site Promotores de Salud psychoeducation related to SARS-CoV-2 health related behaviors. Outreach conducted by promotores occurs to increase attendance at the testing events. Outreach is culturally responsive (e.g., culturally tailored radio announcements, social media posts, community canvassing, referral by community leaders).
Control treatment status sites consisted of sites with "business as usual" outreach methods. No additional outreach activities were completed and promotores were not on site to deliver the Promotores de Salud intervention.
Unknown treatment status participants had data collected at an intervention or control site, but their exposure status is unknown.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
1623
Other Number Affected:
0
Other Number At Risk:
1623
Study:
NCT05082935
Results Section:
NCT05082935
Adverse Events Module:
NCT05082935